#United States #New York #Class Action #Rosen Law Firm #MoonLake Immunotherapeutics

Rosen Law Firm Investigates MoonLake Immunotherapeutics Investors

The Rosen Law Firm, a prominent player in the global investment rights law arena, has made headlines by initiating an investigation into possible securities class actions on behalf of shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX). This investigation comes on the heels of allegations suggesting that MoonLake may have disseminated materially deceptive business information to investors, a development that has serious implications for those holding shares in the company.

The Background of the Investigation

On September 29, 2025, prior to the market's opening, MoonLake Immunotherapeutics released a Form 8-K with the Securities and Exchange Commission (SEC), which raised significant concerns. According to this report, the company stated that events in the placebo arm of their VELA-2 clinical trial were unexpectedly high, preventing the study from achieving the requisite statistical significance in its primary endpoint. This revelation triggered an alarming reaction in the stock market, with MoonLake shares suffering a staggering drop of 89.9% on the same day.

Why This Matters to Investors

For individuals who purchased MoonLake securities, there may be potential for compensation without incurring any out-of-pocket fees or expenses thanks to a contingency fee arrangement offered by the Rosen Law Firm. The firm is actively preparing a class action lawsuit aimed at recovering losses for investors adversely affected by this unexpected downturn. The implications of monetary recovery in such situations are critical, as they can alleviate some of the financial burdens faced by affected investors.

How Investors Can Get Involved

Investors interested in joining the class action are encouraged to reach out through the firm’s website or by contacting Phillip Kim, Esq., who can be reached toll-free at 866-767-3653 or via email at [email protected]. The firm is laying the groundwork for this potential class action and urges impacted individuals to take prompt action to preserve their rights.

The Rosen Law Firm's Reputation

The Rosen Law Firm has a storied reputation for effectively advocating on behalf of investors. It is a law firm that stands out in a crowded field, having achieved the largest securities class action settlement against a Chinese company at the time. Recognized for its experience and results, the firm was ranked number one for securities class action settlements by ISS Securities Class Action Services in 2017 and has continued to be ranked among the top four firms in this domain each year since 2013. In total, the firm has recovered hundreds of millions for investors, with more than $438 million secured in just 2019. Laurence Rosen, one of the founding partners, has even been termed a Titan of Plaintiffs' Bar by law360, underscoring the firm’s expertise in navigating the complexities of securities litigation.

What To Expect Moving Forward

For those following this situation, it is essential to stay updated on the details and developments as they unfold. The Rosen Law Firm will continue to share news through their social media channels, including LinkedIn, Twitter, and Facebook, ensuring that investors are equipped with the information they need to make informed decisions.

In closing, the potential securities claims against MoonLake Immunotherapeutics underscore the need for vigilance among investors. As always, selecting qualified legal counsel with a successful track record is paramount in such circumstances. Investors should ensure that they have competent representation to navigate the turbulent waters of securities litigation effectively.

• ---

For more information, please contact:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll-Free: (866) 767-3653
Fax: (212) 202-3827
Email: [email protected]
Website: www.rosenlegal.com